Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Abstract excerpt

Idiosyncratic drug-induced liver injury (DILI) is a rare disease that develops independently of drug dose, route, or duration of administration. Furthermore, idiosyncratic DILI is not a single disease entity but rather a spectrum of rare diseases with varying clinical, histological, and laboratory features. The pathogenesis of DILI is not fully understood. Standardization of the DILI nomenclature and methods to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Chemical and Drug Induced Liver Injury
• Share to Liver